In the News

The biotechnology industry uses advances in genetics research to develop products for human diseases and conditions. This section includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.

Seaweed extract may help design new drugs
Drug resistance is a large and growing problem. On the hunt for fresh sources of drugs, scientists have turned to the seaweed in underwater forests.

Diabetes: Could targeting this protein prevent hypoglycemia?
Could targeting the protein neuronostatin prevent or treat dangerous low blood sugar in people with diabetes who use insulin? A new study investigates.

Fish slime: An answer to antibiotic resistance?
Antibiotic resistance is an increasingly pressing issue for humanity. A recent study dives into the constituents of fish slime to hunt for new antibiotics.

Heart failure: New drug could halt disease and improve heart function
A molecule that stops two proteins from interacting and impairing heart function halted heart failure and improved heart pumping capacity in rats.

93 percent of medications contain 'potential allergens'
Many of the so-called inactive ingredients present in medications could have the potential to cause allergic reactions in some people.

IBD: New approach to symptom relief looks promising
Blocking a protein associated with blood clotting reduced IBD symptoms in mice, offering a promising alternative to therapies that target inflammation.

New drug limits damage to heart muscle from heart attack
Cell death from a heart attack damages heart muscle. Blocking MAP4K4 — a protein that is key to this process — greatly reduced heart injury in mice.

Pancreatic cancer: Two-hit treatment approach shows promise
Autophagy inhibitors could be more potent against pancreatic cancer by first applying a drug that makes the cancer cells dependent on autophagy for energy.

Alzheimer's: 'Holy herb' extract shows promise as future treatment
A laboratory screen found that a compound in the Yerba santa medicinal plant protects against several age-related triggers of death in mouse nerve cells.

Bacteria living on insects could provide new antibiotics
Insects harbor bacteria that protect them from infection. Tapping this source could yield new antibiotics to combat the growing threat of drug resistance.

Simple drug formula regenerates brain cells
Scientists have shown how a drug cocktail of four compounds can convert glia, or support cells, next to damaged neurons into new working neurons.

Colorectal cancer: Scientists halt growth with cannabinoid compounds
Scientists have identified a number of synthetic cannabinoid compounds that can halt the growth of several types of human colorectal cancer cells.

Antibiotics disrupt gut bacteria, impact bone health
According to one intriguing new study, antibiotics may disrupt bone health by interacting with gut bacteria and the immune system.

Multiple sclerosis: Small molecule could delay onset
Neuroprotective treatment with the small molecule Sephin1, significantly delayed loss of myelin and damage to cells in a mouse model of MS.

Breast cancer: Changing tumor cells into fat cells stops spread
By exploiting cancer cells' innate adaptability, scientists halt invasive spread in mice by transforming malignant breast cancer cells into fat cells.

Triple-negative breast cancer responds to new dual-target therapy
An experimental therapy that targets two growth pathways reduced cancer cell proliferation and spread in mice with triple-negative breast cancer.

Read More

News Releases

Keep up on the latest news from VMS BioMarketing. Links to featured news releases are posted below.

New Business Development VP Karen Josey Will Build Awareness of Clinical Educators to Improve Patient Compliance as VMS BioMarketing Moves Into Phase II-IV Clinical Trial Space
Posted on Wednesday January 16, 2019

Helping Patients Set Healthy Goals for the New Year
Posted on Wednesday January 02, 2019

VMS BioMarketing Clinical Educator Teresita Buenrostro shares how to help patients improve self-management of chronic illnesses

VMS BioMarketing Launches New Corporate Website
Posted on Tuesday June 05, 2018

New website provides practical solutions to challenges of medication adherence

VMS to Sponsor Oncology Nursing Society 'Mara' Lecture Addressing Topics Related to the Psychosocial Aspects of Cancer
Posted on Tuesday May 15, 2018

VMS BioMarketing Clinical Educators Gear Up to Help Reduce HIV Risks
Posted on Wednesday May 02, 2018

Healthcare provider education aimed at preventing opioid-related HIV outbreaks

Awards + Recognition

VMS has experienced more than two decades of success by strategically partnering with our clients to continually provide best-in-class service. We have been recognized for our key contributions and impressive growth.

For the third consecutive year, rated a Great Place to Work® by the experts who produce FORTUNE's 100 Best Companies to Work For® list

Named one of the 2017 Best Workplaces for Giving Back by Fortune magazine and a Great Place to Work
Selected by Fortune magazine as one of the "100 Best Medium Workplaces" in America, with rankings based on anonymous surveys from more than 52,000 employees at Great Place to Work®-certified companies
Great Place to Work® and Fortune magazine recognized VMS BioMarketing as one of the 100 Best Workplaces for Women
Selected as a "Most Valuable Patient Initiative" Finalist and a "Most Valuable HCP Initiative" Finalist at the 2017 Eyeforpharma Awards
Named three times as one of Inc. 500's "Fastest Growing Companies in America"
Recognized by a Fortune 500 pharmaceutical client with a "Global Supplier of the Year" award
Recognized by the Edward Lowe Foundation as one of the "Indiana Companies to Watch" in 2008
Recognized by Working Mother magazine in 2008 as a Top 25 outstanding family-friendly company
Received "Family Friendly Workplace" award from the Indiana Youth Institute in 2008
Highlighted as a "Growth 100" company by the Kelley School of Business Johnson Center for Entrepreneurship and Innovation
Selected as one of Ernst and Young's "Entrepreneur of the Year" finalists
Listed in the top five of the Best Places to Work in Indiana three years in a row